Accelerator Mass Spectrometry (AMS)

Pharmaron is the world leader in the use of Accelerator Mass Spectrometry (AMS) technology in pharmaceutical, food technology, animal healthcare and agrochemical applications.  In January 2017 Pharmaron acquired Xceleron, based in Germantown, Maryland, a globally-leading Accelerator Mass Spectrometry (AMS) specialist for life sciences.  Our team is primarily focused on pharmaceutical research and development employing AMS as a unique, ultra-sensitive analytical tool to support both clinical and non-clinical investigations.

14C Radiolabelled Microtracers Ultra-sensitive Analytical Methodology Accelerated Clinical Development Microdosing Phase 0 Clinical PK with Absolute Bioavailability Mass Balance Using AMS Metabolite Profiling Using AMS Non-clinical Studies Using Radiolabelled Compounds 14C Radiolabels and AMS for Biologics

Learn About Our Services